Novartis Soars on New Drug Approval, But Its Long-Term Investment Case Runs Much Deeper

Life Science

Johnson & Johnson’s Market Cap Surpasses $500 Billion: Why Is Wall Street Bullish on J&J?

Life Science

Novo Nordisk’s Stock Rebounds, Leveraging New-Generation Weight Loss Drugs and Price Reduction Strategy

Life Science

Symbotic Stock Soars 39% After Stellar Earnings and Strategic Breakthrough into Healthcare Automation

Life Science, Technology

Top Growth Stocks for 2026: Targeting Consistent 15%+ Revenue Growth

Life Science, Technology

Eli Lilly Joins the Trillion-Dollar Club, Powered by Blockbuster Weight-Loss Drugs

Life Science

Aging Population, Growing Opportunity: A Guide to Investing in Healthcare REITs

Life Science, Real Estate

Analyzing the Drivers Behind Johnson & Johnson’s Stock Price Increase This Month

Life Science

Benefiting from Both Capacity Expansion and Drug Development,  AstraZeneca’s Stock Performance Shines

Life Science

Merck’s $92 Billion Acquisition of Cidara Bets on New Flu Drug

Life Science

Abbott to Acquire Exact Sciences in a $21 Billion Deal, Boosting Cancer Diagnostics Push

Life Science

Johnson & Johnson Stock Surges on Strong Earnings and Strategic Acquisition

Life Science

Acquisition Rumors Drive Exact Sciences Stock Price Surge, Market Watches Potential Deal Progress

Life Science

Dividend Kings Expand to 56 Members, Healthcare Sector Contributes Four Resilient Players

Life Science

Why Is UnitedHealth Group Undervalued and Poised to Outperform Palantir?

Life Science